Updated Results of the COVID-19 in MS Global Data Sharing Initiative
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updated Results of the COVID-19 in MS Global Data Sharing Initiative
Authors
Keywords
-
Journal
Neurology-Neuroimmunology & Neuroinflammation
Volume 9, Issue 6, Pages e200021
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-08-30
DOI
10.1212/nxi.0000000000200021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
- (2021) Ricardo Alonso et al. Multiple Sclerosis and Related Disorders
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
- (2021) Amber Salter et al. JAMA Neurology
- Multiple sclerosis, rituximab, and COVID‐19
- (2021) Annette Langer‐Gould et al. Annals of Clinical and Translational Neurology
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
- (2021) Maria Pia Sormani et al. Annals of Clinical and Translational Neurology
- SARS-CoV-2 Infection in Multiple Sclerosis
- (2021) Georgina Arrambide et al. Neurology-Neuroimmunology & Neuroinflammation
- Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
- (2021) Carla Tortorella et al. NEUROLOGY
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
- (2021) Farren Basil Shaw Briggs et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19 in people with multiple sclerosis: A global data sharing initiative
- (2020) Liesbet M Peeters et al. Multiple Sclerosis Journal
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- B cell depletion in the treatment of multiple sclerosis
- (2019) Kjell-Morten Myhr et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started